首页   >  
GPCR/G Protein
  >  
Oxytocin Receptor

所有产品分类

所有产品

信号通路

研究领域

天然产物

抗体

多肽

催化剂

杂质对照品

医药中间体

基础原料

Oxytocin Receptor

结构式 货号 产品名称 CAS号
L-368,899 hydrochloride 结构式
BCP38590 L-368,899 hydrochloride 160312-62-9
L-368,899 hydrochloride is the hydrochloride salt of L-368,899, which is a non-peptide, orally active and potent oxytocin receptor antagonist with IC50 value of 8.9 nM.
WAY 267464 结构式
BCP35975 WAY 267464 847375-16-0
WAY 267464 is a potent, selective non-peptide oxytocin receptor (OTR) agonist (Ki = 58.4 nM at human OTR). Exhibits anxiolytic-like effects. May have therapeutic potential for the treatment of psychosis and schizophrenia.
LIT-001 TFA 结构式
BCP32617 LIT-001 TFA 2245072-21-1
LIT-001 is the First Nonpeptide Oxytocin Receptor Agonist that Improves Social Interaction in a Mouse Model of Autism.
LIT-001 结构式
BCP31983 LIT-001 2245072-20-0
LIT-001 is the first potent nonpeptide agonist of oxytocin receptor (OT-R).
Alisertib 结构式
BCP28930 Alisertib 1477482-19-1
Alisertib, also known as OBE001 or Erlosiban, is a novel, orally active nonpeptide oxytocin receptor antagonist under development for the treatment of preterm labor and improvement in embryo implantation and pregnancy rate in assisted reproductive technology (ART).
PF-3274167 结构式
BCP08878 PF-3274167 900510-03-4
PF-3274167 is a high-affinity nonpeptide oxytocin receptor (OTR) antagonist, with Ki of 9.5 nM.
Atosiban 结构式
BCP02053 阿托西班 90779-69-4
Atosiban, a nonapeptide, desamino-oxytocin analogue, is a competitive inhibitor of the hormones oxytocin and vasopressinv.
Oxytocin Acetate 结构式
BCP02057 缩宫素 50-56-6
Oxytocin(Syntocinon) is a nine amino acid peptide that is synthesized in hypothalamic neurons and transported down axons of the posterior pituitary for secretion into blood.
Carbetocin 结构式
BCP11964 卡贝缩宫素 37025-55-1
Carbetocin is an obstetric drug used to control postpartum hemorrhage and bleeding after giving birth; an agonist at peripheral oxytocin receptors.
Oxytocin C-terminal tripeptide 结构式
BCP13982 Oxytocin C-terminal tripeptide 2002-44-0
Oxytocin C-terminal tripeptide is shown to be effective in treating human depression with greater efficacy and faster onset of action than traditional anti-depressants. Also, it is used in the synthesis of novel analogs to be tested for their ability to enhance the binding of [3H]-N-propylnorapomorphine to short isoform of human dopamine D2 receptors.
12下一页共 11 条记录 1 / 2 页 
2853530913